Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-30.41	21.92	31.50
Graham Fair Price	4.68	12.15	11.61
PEG	78.47	-0.07	-0.31
Price/Book	-2.76	0.94	0.96
Price/Cash Flow	312.81	70.28	17.03
Prices/Earnings	-6.66	13.74	-14.72
Price/Sales	-5.29	2.26	2.38
Price/FCF	312.81	70.28	17.03
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	26.08	0.26	0.21
Operating Margin	178.45	0.08	0.03
ROA	11.11	< 0.005	< 0.005
ROE	-0.02	0.02	4.18
ROIC	0.05	0.02	-70.03
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.09	-0.12	-19.51
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.78	1.93	-30.40
EPS QOQ	-0.48	2.06	333.55
FCF QOQ	0.08	-0.76	888.05
Revenue QOQ	-0.04	0.05	20.36
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	74.15	82.63	11.43
Days Sales Outstanding (DSO)	54.20	46.73	-13.78
Inventory Turnover	1.21	1.09	-10.25
Debt/Capitalization	0.28	0.34	20.53
Quick Ratio	0.79	0.72	-8.05
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	19.12	19.61	2.56
Cash	2.17	2.50	15.35
Capex	-0.40	-0.54	-33.51
Free Cash Flow	1.08	0.26	-75.84
Revenue	7.74	8.15	5.30
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.45	1.47	1.44
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.11	6.80	-25.36
Naive Interpretation	Member

06 - Financial Health · Weak

Rating